50 related articles for article (PubMed ID: 24553368)
1. Histological subtypes of lung cancer in Chinese males from 2000 to 2012.
Zou XN; Lin DM; Wan X; Chao A; Feng QF; Dai Z; Yang GH; Lv N
Biomed Environ Sci; 2014 Jan; 27(1):3-9. PubMed ID: 24553368
[TBL] [Abstract][Full Text] [Related]
2. [Effect of Smoking on Lung Cancer Histology and Its Epidemiology in Chinese Male].
Jia M; Li J; Lin H; Zou X; Zhao P
Zhongguo Fei Ai Za Zhi; 2017 Aug; 20(8):516-521. PubMed ID: 28855031
[TBL] [Abstract][Full Text] [Related]
3. Histological subtypes of lung cancer in Chinese women from 2000 to 2012.
Zou XN; Lin D; Chao A; Wan X; Feng Q; Li J; Yang J; Yang GH; Lv N
Thorac Cancer; 2014 Sep; 5(5):447-54. PubMed ID: 26767037
[TBL] [Abstract][Full Text] [Related]
4. Histopathological characterization of lung tumours at the University Teaching Hospital, Lusaka, Zambia: a pilot study.
Tembo MJ; Kayamba V; Zulu E
Afr Health Sci; 2022 Dec; 22(4):31-36. PubMed ID: 37092044
[TBL] [Abstract][Full Text] [Related]
5. Non-small cell lung cancer in China.
Chen P; Liu Y; Wen Y; Zhou C
Cancer Commun (Lond); 2022 Oct; 42(10):937-970. PubMed ID: 36075878
[TBL] [Abstract][Full Text] [Related]
6. Prediction of the Invasiveness of Ground-Glass Nodules in Lung Adenocarcinoma by Radiomics Analysis Using High-Resolution Computed Tomography Imaging.
Zhang T; Li X; Liu J
Cancer Control; 2022; 29():10732748221089408. PubMed ID: 35848489
[TBL] [Abstract][Full Text] [Related]
7. Primary lung adenocarcinoma complicated with lung hamartoma: A case report and literature review.
Wang L; Zhou L; Zhang J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 47(4):529-534. PubMed ID: 35545349
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppressor miR‑613 induces cisplatin sensitivity in non‑small cell lung cancer cells by targeting GJA1.
Luo J; Jin Y; Li M; Dong L
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760215
[TBL] [Abstract][Full Text] [Related]
9. Trends and risk factors of lung cancer in China.
He S; Li H; Cao M; Sun D; Lei L; Li N; Peng J; Chen W
Chin J Cancer Res; 2020 Dec; 32(6):683-694. PubMed ID: 33446992
[TBL] [Abstract][Full Text] [Related]
10. miR-335-5p Regulates Cell Cycle and Metastasis in Lung Adenocarcinoma by Targeting CCNB2.
Wang X; Xiao H; Wu D; Zhang D; Zhang Z
Onco Targets Ther; 2020; 13():6255-6263. PubMed ID: 32636645
[TBL] [Abstract][Full Text] [Related]
11. Clinical profile of lung cancer in North India: A 10-year analysis of 1862 patients from a tertiary care center.
Mohan A; Garg A; Gupta A; Sahu S; Choudhari C; Vashistha V; Ansari A; Pandey R; Bhalla AS; Madan K; Hadda V; Iyer H; Jain D; Kumar R; Mittal S; Tiwari P; Pandey RM; Guleria R
Lung India; 2020; 37(3):190-197. PubMed ID: 32367839
[TBL] [Abstract][Full Text] [Related]
12. [Trend Analysis of Clinical Epidemiological Characteristics of Lung Cancer in Yunnan Cancer Hospital from 2005 to 2014].
Lin Y; Zhang Q; Lu Y; Huang Y; Ma J; Zhou Y
Zhongguo Fei Ai Za Zhi; 2020 Mar; 23(3):142-149. PubMed ID: 32102133
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a novel monoclonal antibody mAb109 by immuno-PET/fluorescent imaging for noninvasive lung adenocarcinoma diagnosis.
Zhu H; Liu TL; Liu CH; Wang J; Zhang H; Dong B; Shen J; Zhao CK; Li ZF; Cheng Z; Yang Z
Acta Pharmacol Sin; 2020 Jan; 41(1):101-109. PubMed ID: 31534200
[TBL] [Abstract][Full Text] [Related]
14. Tobacco smoking and trends in histological subtypes of female lung cancer at the Cancer Hospital of the Chinese Academy of Medical Sciences over 13 years.
Zeng Q; Vogtmann E; Jia MM; Parascandola M; Li JB; Wu YL; Feng QF; Zou XN
Thorac Cancer; 2019 Aug; 10(8):1717-1724. PubMed ID: 31293059
[TBL] [Abstract][Full Text] [Related]
15. Tobacco and the lung cancer epidemic in China.
Parascandola M; Xiao L
Transl Lung Cancer Res; 2019 May; 8(Suppl 1):S21-S30. PubMed ID: 31211103
[TBL] [Abstract][Full Text] [Related]
16. Sequential therapy according to distinct disease progression patterns in advanced
Xu H; Ma D; Yang G; Li J; Hao X; Xing P; Yang L; Xu F; Wang Y
Chin J Cancer Res; 2019 Apr; 31(2):349-356. PubMed ID: 31156305
[TBL] [Abstract][Full Text] [Related]
17. Favorable predictors for survival in advanced ALK-positive non-small cell lung cancer patients beyond crizotinib resistance.
Xu H; Yang G; Yang L; Yang Y; Ma D; Li J; Hao X; Xing P; Wang Y
Thorac Cancer; 2019 May; 10(5):1096-1102. PubMed ID: 30920172
[TBL] [Abstract][Full Text] [Related]
18. Validation of stage groupings in the eighth edition of the tumor node metastasis classification for lung adenocarcinoma.
Yu W; Zhao Q; Xia C; Dong M; Liu J; Li X; Zhao H; Chen G; Liu H; Chen J
Thorac Cancer; 2019 Mar; 10(3):483-491. PubMed ID: 30648815
[TBL] [Abstract][Full Text] [Related]
19. Comparing first-line treatment patterns and clinical outcomes of patients with pan-negative advanced non-squamous non-small cell lung cancer.
Xu H; Xu F; Zhu W; Ying J; Wang Y
Thorac Cancer; 2018 Aug; 9(8):1005-1011. PubMed ID: 29917332
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
